Sea You at Fetch Long Beach
|Videos|August 27, 2022

Veterinary oncologist provides options and hope to clients

Kansas City

Andi Flory, DVM, DACVIM (Oncology), chief medical officer of PetDx and 2022 Veterinary Heroes™ honoree, discusses what makes the oncology speciality unique in veterinary practice.

Andi Flory, DVM, DACVIM (Oncology), chief medical officer of PetDx, discusses what makes the oncology speciality unique in veterinary practice, during an interview with dvm360®. Flory is a 2022 Veterinary Heroes™ honoree for oncology, and was recognized during an awards dinner at the Fetch dvm360® Conference in Kansas City, Missouri, with recipients in various areas of expertise throughout the veterinary industry.

Andi Flory, DVM, DACVIM (Oncology): We develop such an immediate and intense bond with families. I think all veterinarians do. And, a lot of veterinarians, they know a family from the beginning of [a pet's] life all the way to the end of their life. And a lot of times, [veterinary oncologists are} coming in there at this really intense and really heavy moment and then we get to, kind of, tell them that there are options and help them understand what they can do, and provide them a little bit of hope at a really dark time.


Related to this article

Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Inside veterinary social work
In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.
Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.